Strategic axes
Micro and nanotechnologies for health
The healthcare sector relies on innovative technologies to prevent and predict diseases, improve medical diagnostics, enhance biotherapy production, and better monitor and treat patients. With its multidisciplinary expertise: microelectronics, biology, physics, chemistry, artificial intelligence, and more… CEA-Leti drives this transformation by developing industrial-scale solutions, some of which are world firsts.
4 Research application domains
Credits: TOP IMAGESADOBESTOCK, PIXEL-SHOT/ADOBESTOCK, LITTLEWOLF1989/ADOBESTOCK, KOSSSMOSSS/ADOBESTOCK
Linking human, animal, and environmental health
CEA-Leti aligns with the "One Health" initiative launched in 2010, notably by the WHO and UNEP*. One Health works in a coordinated manner on three interdependent areas: human health, animal health, and environmental health. 60% of human infectious diseases originate from animals. Human pandemics and zoonoses are interconnected and cannot be addressed separately.
*UNEP: United Nations Environment Programme
Over 350 active patents
The technological foundation of CEA-Leti’s health innovations includes microelectronics, optics, photonics, algorithms, AI, sensors, actuators, imagers, electronic systems, communication, and energy efficiency of devices. These expertise areas interface with life sciences through additional specialties such as biomaterials, microfluidics, and sample preparation. Advances are protected by over 350 active patents. Health research accounts for more than 10% of CEA-Leti’s activities. It is equally driven by an applied department (the Department of Technologies for Health Innovation) and four expert departments in silicon technologies, optics, electronic components, system approaches, telecommunications, and energy management. Additionally, CEA-Leti operates Clinatec, a one-of-a-kind biomedical research center: a clinical sector with six rooms, an operating theater, intraoperative MRI, magnetoencephalography (MEG), a scanner, and more.
Promoting startup creation
To achieve strong societal impact, create jobs, and contribute to French and European sovereignty in health, CEA-Leti fosters industrial partnerships and transfers its technologies to biotechnology companies, pharmaceutical laboratories, and medical equipment manufacturers. It collaborates with major industry players such as Sanofi, Ceva, Onward Medical, Thales, and Trixell. The dissemination of technologies also involves the creation of spin-out start-ups from its research, often led by former research engineers. Examples include: Fluoptics (surgical guidance), Avalun (point-of-care diagnostics), Mag4Health (magnetoencephalography), Admir (cancer diagnostics), Injectpower (microbatteries for medical implants), Remedee Labs (pain treatment), Nawu Diagnostics (veterinary diagnostics).